Please login to the form below

Not currently logged in
Email:
Password:

The Netherlands

This page shows the latest The Netherlands news and features for those working in and with pharma, biotech and healthcare.

COVID-19 delays Pfizer, Mylan’s generics merger and spin-out

COVID-19 delays Pfizer, Mylan’s generics merger and spin-out

disruption caused by the coronavirus, and is now scheduled to take place in the latter half of this year. ... It’s due to be held in the Netherlands, where Mylan is domiciled, and for now the country has a ban on meetings.

Latest news

  • PharmaLex announces joint venture with Vintura PharmaLex announces joint venture with Vintura

    The two organisations will continue to operate under their respective, well-established brands. ... Vintura is a strategy and organisation consultancy with speciality in healthcare and life sciences, and has offices based in Amsterdam, the Netherlands

  • OPEN Health expands global footprint with Pharmerit International integration OPEN Health expands global footprint with Pharmerit International integration

    This means OPEN Health will now have 700 employees in 15 offices across six countries including the US, UK, The Netherlands, Germany, India and China. ... The two organisations have many synergies and fill important gaps for each other,” said Jenny

  • New results back Sangamo, UniQure haemophilia gene therapies New results back Sangamo, UniQure haemophilia gene therapies

    In the April update both subjects saw Factor VIII levels reach normal ranges. ... There was also good news for the Netherlands-headquartered company from long-term follow-up of patients treated with AMT-060, an earlier version of its gene therapy that

  • Scancell preps phase 2 challenge for melanoma vaccine Scancell preps phase 2 challenge for melanoma vaccine

    trial are in place and the clinical trial centres are ready to start recruitment. ... Lead candidate Modi-1 has been synthesised at scale by contract manufacturer Polypeptide Group in the Netherlands and formulation work is now ongoing to prepare for

  • AbbVie’s upadacitinib tops Humira again in arthritis trial AbbVie’s upadacitinib tops Humira again in arthritis trial

    The lead investigator in the SELECT-EARLY trial, Prof Ronald van Vollenhoven of the Amsterdam Rheumatology and Immunology Centre in the Netherlands, said that while remission is the primary treatment goal ... that with upadacitinib nearing approval

More from news
Approximately 3 fully matching, plus 171 partially matching documents found.

Latest Intelligence

  • Emerging use cases of blockchain in healthcare and the life sciences

    What is the blockchain? The blockchain is a decentralised, real-time list of records, which are called ‘blocks’. ... The Prescrypt project, spearheaded by Deloitte in the Netherlands, is pursuing a completely different focus by working to put

  • Will biosimilars ever catch on in the US? Will biosimilars ever catch on in the US?

    Large biosimilar discounts have also been realised in the Netherlands, Poland, Spain and the UK. ... The drug companies apply for new patents over and over again,” she said.

  • Creating value from value-based healthcare Creating value from value-based healthcare

    The Netherlands has enthusiastically embraced the concept, with a commitment by. ... The pharmaceutical industry is very well positioned to be a major player in VBHC.

  • Encouraging signs in biomarker R&D Encouraging signs in biomarker R&D

    Finding and using such biomarkers is complicated, according to John Haanen, Professor of Translational Immunotherapy of Cancer at Leiden University Medical Centre in the Netherlands and European Society for Medical Oncology ... Gareth Macdonald is a

  • In conversation with Pfizer’s Erik Nordkamp In conversation with Pfizer’s Erik Nordkamp

    10.8% of GDP is spent on healthcare in the Netherlands versus 9.8% in the UK. ... Since the Netherlands is among the five wealthiest countries in the eurozone, the Dutch have high expectations.

More from intelligence
Approximately 1 fully matching, plus 31 partially matching documents found.

Latest appointments

  • Genmab hires first chief operating officer Genmab hires first chief operating officer

    He brings both strategic and operational leadership experience to the company, as well as a consistent track record of growth across a number of geographical regions. ... Mancini will be based in Princeton, New Jersey, US but will also travel regularly

  • Swiss biotech Inositec appoints new chief medical officer Swiss biotech Inositec appoints new chief medical officer

    Novartis as well as heading their clinical operations team in the Netherlands. ... in the vascular calcification space and fine-tune our clinical strategy in view of first-in-human studies in 2019.”.

  • Bayer appoints Wolfgang Nickl as chief financial officer Bayer appoints Wolfgang Nickl as chief financial officer

    He will succeed Johannes Dietsch on June 1, 2018. Bayer has appointed a new chief financial officer in the form of Wolfgang Nickl, who will take over from Johannes Dietsch on ... Nickl has already been the CFO of several companies in the United States

  • Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel

    Verwiel has also served at Merck &Co, where he was vice president and was general manager at Merck Sharpe Dohme’s operations in the Netherlands. ... They bring decades of scientific, operational, business and strategic experience in the pharmaceutical

  • Hywel Day joins Napp Pharmaceuticals Hywel Day joins Napp Pharmaceuticals

    At that company he served in a general manager role, based in The Netherlands, where he led the business through a substantial transformation, which involved a significant cultural shift and a ... on our promises to the NHS, patients, our business

More from appointments
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 18 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...

Latest intelligence

OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses...
OPEN Health use PR to support clinical trial recruitment
International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2...
Covid-19: what could it mean for the diabetic population?
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it...

Infographics